Full Name
Dr. Cristina Papayannidis MD, PhD
Job Title
Professor
Company/Affiliation
University of Bologna
Speaker Bio
Dr. Cristina Papayannidis is an Italian hematologist based in Bologna, Italy, with clinical and research expertise in hematological disorders, with a particular focus on Acute Myeloid and Lymphoid Leukemias. She graduated from Bologna University in 2005 and trained at the Institute of Hematology "Seragnoli," under the mentorship of Prof. Giovanni Martinelli. She has been an Adjunct Professor of Hematology at the same university since 2022.
Dr. Papayannidis has extensive experience in modern hematology, including advanced diagnostic approaches and innovative therapeutic strategies. Her work reflects a strong commitment to evidence-based medicine, multidisciplinary collaboration, and the translation of scientific research into improved patient care. She is actively engaged in clinical research, contributing to the development and evaluation of novel treatments aimed at improving outcomes for patients with Acute Leukemias.
In addition to her clinical activity, Dr. Papayannidis participates in academic and educational initiatives, contributing to the training of medical students, residents, and healthcare professionals in the field of hematology. She is recognized for her patient-centered approach and her dedication to advancing standards of care through continuous clinical and scientific engagement.
Dr. Papayannidis is a member of ASH, AACR, EHA, SIE, SIES, ESMO, and SOHO. She has been part of the EHA AML SWG since 2023, a faculty member of the ESMO Hematological Malignancies Committee since 2021, and a member of the ALL Subcommittee of the Education Committee for SOHO since 2025.
She is the author of more than 180 peer-reviewed publications (Scopus H-index 40) and has been a speaker at more than 200 national and international congresses. She has served on the editorial boards of several scientific journals.
Dr. Papayannidis has extensive experience in modern hematology, including advanced diagnostic approaches and innovative therapeutic strategies. Her work reflects a strong commitment to evidence-based medicine, multidisciplinary collaboration, and the translation of scientific research into improved patient care. She is actively engaged in clinical research, contributing to the development and evaluation of novel treatments aimed at improving outcomes for patients with Acute Leukemias.
In addition to her clinical activity, Dr. Papayannidis participates in academic and educational initiatives, contributing to the training of medical students, residents, and healthcare professionals in the field of hematology. She is recognized for her patient-centered approach and her dedication to advancing standards of care through continuous clinical and scientific engagement.
Dr. Papayannidis is a member of ASH, AACR, EHA, SIE, SIES, ESMO, and SOHO. She has been part of the EHA AML SWG since 2023, a faculty member of the ESMO Hematological Malignancies Committee since 2021, and a member of the ALL Subcommittee of the Education Committee for SOHO since 2025.
She is the author of more than 180 peer-reviewed publications (Scopus H-index 40) and has been a speaker at more than 200 national and international congresses. She has served on the editorial boards of several scientific journals.
Speaking At
